Concurrently, we analyzed the levels of cytokines, such as IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ, and there were no significant differences in EBV-EBER- or LMP-1-positive and -negative patients with HL. This evidence concerns the gene IL2 and Hodgkins lymphoma.